The emerging approach of the medication represents a significant advance in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets dual pathways – the GLP-1 hormone and https://tirzepatidepeptide182033.bloginwi.com/75871907/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment